NorthCrest Asset Manangement’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
NorthCrest Asset Manangement's AMGN Position: Q2 2026 in Review
NorthCrest Asset Manangement increased its Amgen (AMGN) stake by 3.4% in Q2 2026, buying an estimated $837K and bringing the position to 73,601 shares worth $26.8M. The position accounts for 0.69% of the portfolio, ranked #25.
NorthCrest Asset Manangement first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $33.3M in Q4 2025. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- NorthCrest Asset Manangement held 73,601 shares of Amgen worth $26.8M as of Q2 2026.
- NorthCrest Asset Manangement bought 2,444 Amgen shares in Q2 2026, an estimated $837K.
- Amgen made up 0.69% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #25 holding.
- NorthCrest Asset Manangement first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- NorthCrest Asset Manangement's Amgen position peaked at $33.3M in Q4 2025.
- 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.